Skip to content
Search

Latest Stories

Lloyds Pharmacy’s decision to close all Sainsbury’s branches worries pharmacy bodies

The pharmacy bodies have expressed a deep concern over Lloyds Pharmacy ’s announcement on plans to close all pharmacy branches located in Sainsbury’s before the end of 2023.

Pharmaceutical Services Negotiating Committee (PSNC) Chief Executive Janet Morrison said: “This significant shrinkage by the second largest pharmacy chain is an extremely worrying development and one of the clearest signals yet of just how much all community pharmacies are struggling to make ends meet. We know that many are at breaking point.”


She added: “We understand that LloydsPharmacy will be in touch directly with affected staff and patients at this difficult time. As these pharmacies close, other pharmacies locally will be braced for even more pressures as they try to cope with increased demand.”

“The announcement by LloydsPharmacy will be of concern to staff, patients, the public and the community pharmacy sector alike,” Malcolm Harrison, Chief Executive of the Company Chemists’ Association (CCA).

Pharmacists, and other employees, working at pharmacies owned and operated by LloydsPharmacy in Sainsbury’s have been told that the group of more than 200 pharmacies will be closed this year as LloydsPharmacy will be ending their relationship with the supermarket chain.

The Pharmacist Defence Association (PDA) Union will provide PDA members with information, support and representation in order that they are aware of and can exercise their rights at work in relation to this situation.

As the recognised trade union at LloydsPharmacy, PDA officials were given confidential notice before the announcement and are able to continue to represent the interests of pharmacists in discussions with the company.

Mark Pitt, Assistant General Secretary of the PDA Union said, “We have seen many disposals of Lloyds Pharmacy branches over recent months and we know more may occur, however for every disposal there has been a buyer, therefore patients and communities have seen no reduction in availability, the pharmacy network has not lost capacity and there were no job losses.

This situation is different and means significant reductions in access to a pharmacy for patients and we expect those who represent communities to be concerned about the loss of a key part of their local NHS service.

Forward-thinking governments around the UK are seeking to make greater use of pharmacies as the most accessible contact point in the NHS, to reduce pressure on other parts of the healthcare system, so there should be greater community pharmacy capacity, not less.”

According to PSNC, the sharp decline in community pharmacy funding combined with workforce and other pressures is making it ‘increasingly difficult to sustain services and impossible to do more’.

The committee stressed that pharmacies urgently need investment from Government to ensure they can continue to offer the services that so many patients rely on and this is why the sector has this week announced its #saveourpharmacies campaign.

Morrison said: “Without further investment, we believe more permanent closures are likely and this will only increase the risk of serious difficulty for patients’ in accessing services and medicines: Government must not allow this to happen. I am calling on Ministers to meet me for meaningful talks to avoid such a catastrophe.”

“Policymakers cannot escape the fact that the funding model for community pharmacy is broken,” said Harrison.

“As we and other pharmacy bodies have warned recently, we are at an indisputable fork in the road for the NHS. At a time when General Practice and the NHS is struggling with ever-increasing demand, allowing the community pharmacy network to wither and decline will make no sense to patients and the public. Again, we call on the Government to act.

If new and recurrent funding is not forthcoming, it is very likely that the rate of permanent closures will increase with far-reaching impacts on the capacity and resilience of the pharmacy network.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less